Researchers assessed changes in the prevalence of diversity language in NIH-awarded grants following the US election in 2024.

Significant treatment options are changing the management of CLL, according to research presented at the ASH Annual Meeting 2025.

Use of tanning beds more than doubles the risk of developing melanoma by increasing the mutation burden in melanocytes, including at skin sites with ...

In this study, researchers aimed to determine whether ctDNA is detectable in other bodily fluids besides blood, and to characterize any ctDNA they were able to detect.

Cancer patients and survivors are more likely to report housing and utility insecurity than those who do not have a history of cancer, according research ...

The latest data released at ASH 2025 offer new combination therapies for the treatment of multiple myeloma and new insights into the disease.

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

Dr Rahul Banerjee discusses ASH 2025 and bispecific antibodies in myeloma, including data from MajesTEC-3, IFM2021-01, and ...

In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.

Overall survival data showed a 50% reduction in the risk of death with the regimen compared with surgery alone.

High rates of vulnerability on a geriatric assessment were identified in a cohort of fit patients aged 60 years or older with acute myeloid leukemia.

(HealthDay News) — For women with a history of breast cancer, real (RA) and sham acupuncture (SA) produce clinically meaningful improvements in perceived cognitive impairment, according to a study ...